Models and Progress

  1. Dodd PJ, White RG, Corbett EL. Periodic active case finding for TB: when to look? PLoS One. 2011;6(12):e29130. doi: 10.1371/journal.pone.0029130. Epub 2011 Dec 22. [Full Text]
  2. Andrews JR, Lawn SD, Dowdy DW, Walensky RP. Challenges in evaluating the cost-effectiveness of new diagnostics for HIV-associated tuberculosis. Clin Infect Dis. 2013 Jun 20. [Epub ahead of print] PubMed PMID: 23788239. [PubMed Abstract]
  3. Zwerling A, Dowdy D. Economic evaluations of point of care testing strategies for active tuberculosis. Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):313-25. doi: 10.1586/erp.13.27. PubMed PMID: 23763529. [PubMed Abstract]
  4. Dowdy DW, Dye C, Cohen T. Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list' [Review article]. Int J Tuberc Lung Dis. 2013 May;17(7):866-77. doi: 10.5588/ijtld.12.0573. PubMed PMID: 23743307. [PubMed Abstract]
  5. Owens JP, Fofana MO, Dowdy DW. Cost-effectiveness of novel first-line treatment regimens for tuberculosis. Int J Tuberc Lung Dis. 2013 May;17(5):590-6. doi: 10.5588/ijtld.12.0776. PubMed PMID: 23575322. [PubMed Abstract]
  6. Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis. 2013 Apr;17(4):552-8. doi: 10.5588/ijtld.12.0627. PubMed PMID: 23485389. [PubMed Abstract]
  7. Dowdy DW, Basu S, Andrews JR. Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. Am J Respir Crit Care Med. 2013 Mar 1;187(5):543-51. doi: 10.1164/rccm.201207-1217OC. Epub 2012 Dec 21. PubMed PMID: 23262515. [PubMed Abstract]